F. Fakhouri and V. Fremeaux-bacchi, Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?, Nat Clin Pract Nephrol, vol.3, issue.12, pp.679-687, 2007.

V. Fremeaux-bacchi, F. Fakhouri, and A. Garnier, Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults, Clin J Am Soc Nephrol, vol.8, issue.4, pp.554-562, 2012.

M. Noris, J. Caprioli, and E. Bresin, Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype, Clin J Am Soc Nephrol, vol.5, issue.10, pp.1844-1859, 2010.

J. Zuber, L. Quintrec, M. Krid, and S. , Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation, Am J Transplant, vol.12, issue.12, pp.3337-3354, 2012.

E. Bresin, D. E. Noris, and M. , Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background, Clin J Am Soc Nephrol, vol.1, issue.1, pp.88-99, 2006.

L. Quintrec, M. Zuber, J. Moulin, and B. , Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome, Am J Transplant, vol.13, issue.3, pp.663-675, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00945715

M. Noris and G. Remuzzi, Atypical hemolytic-uremic syndrome, N Engl J Med, vol.361, issue.17, pp.1676-1687, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01793663

J. Zuber, F. Fakhouri, L. T. Roumenina, C. Loirat, and V. Fremeauxbacchi, Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nat Rev Nephrol, vol.8, issue.11, pp.643-657, 2012.

M. A. Dragon-durey, C. Blanc, A. Garnier, J. Hofer, S. K. Sethi et al., Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS, Semin Thromb Hemost, vol.36, issue.6, pp.633-640, 2010.

C. Parker, Eculizumab for paroxysmal nocturnal haemoglobinuria, Lancet, vol.373, issue.9665, pp.759-767, 2009.

C. M. Legendre, C. Licht, and P. Muus, Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome, N Engl J Med, vol.368, issue.23, pp.2169-2181, 2013.

F. Fakhouri, L. Roumenina, and F. Provot, Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations, J Am Soc Nephrol, vol.21, issue.5, pp.859-867, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00512540

M. Furlan, R. Robles, and M. Galbusera, von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome, N Engl J Med, vol.339, issue.22, pp.1578-1584, 1998.

C. Frank, D. Werber, and J. P. Cramer, Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany, N Engl J Med, vol.365, pp.1771-1780, 2011.

V. Eremina, J. A. Jefferson, and J. Kowalewska, VEGF inhibition and renal thrombotic microangiopathy, N Engl J Med, vol.358, issue.11, pp.1129-1136, 2008.
DOI : 10.1056/nejmoa0707330

K. Lechner and H. L. Obermeier, Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases, Medicine, vol.91, issue.4, pp.195-205, 2012.

V. Majithia and V. Harisdangkul, Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: a frequent and severe consequence of active disease, Rheumatology, vol.45, issue.9, pp.1170-1171, 2006.

M. Sallee, K. Ismail, and F. Fakhouri, Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome, BMC Nephrol, vol.14, p.3, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00780835